A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia
Clinical trial NCT00035191 · COMPLETED
Trial details
- NCT number
- NCT00035191
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-10-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.